Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
Equity futures fell and oil surged as the initial round of U.S.-Iran talks began, setting a tense tone for markets an...
May delivered a sharp reversal for Bitcoin ETFs, with the biggest weekly outflows since January as risk-off trading s...
Major banks are moving to settle tokenized deposits on blockchain rails, aiming to preserve deposits within the regul...
iShares introduces a staking-enabled ETH fund that closely mirrors ETHA but adds monthly cash distributions, altering...
Struggling to keep a budget you can actually follow? This guide breaks budgeting tips into actionable steps with real...
Tightening UK election funding rules are set to change how crypto wealth can fund political campaigns. This could alt...
When a renowned activist investor signals a bold AI bet, markets take notice. Explore how billionaire Bill Ackman bet...
As Synopsys reports strong Q2 results, investors weigh AI-driven catalysts against a heavy debt load and amortization...
Two US-listed spot HYPE ETFs began trading this month and posted a powerful start, with nine straight days of inflows...
Investors are racing to price in the first real revenue opportunities from quantum tech as a new federal funding push...